ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
BioCardia Inc

BioCardia Inc (BCDA)

2.77
-0.14
(-4.81%)
Closed July 23 4:00PM
2.7487
-0.0263
(-0.95%)
After Hours: 7:51PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
2.7487
Bid
2.70
Ask
2.73
Volume
20,831
2.70 Day's Range 2.96
2.62 52 Week Range 23.25
Market Cap
Previous Close
2.91
Open
2.91
Last Trade Time
Financial Volume
$ 58,181
VWAP
2.793
Average Volume (3m)
247,379
Shares Outstanding
1,820,274
Dividend Yield
-
PE Ratio
-0.44
Earnings Per Share (EPS)
-6.36
Revenue
477k
Net Profit
-11.57M

About BioCardia Inc

BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus o... BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
1970
BioCardia Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker BCDA. The last closing price for BioCardia was $2.91. Over the last year, BioCardia shares have traded in a share price range of $ 2.62 to $ 23.25.

BioCardia currently has 1,820,274 shares outstanding. The market capitalization of BioCardia is $5.30 million. BioCardia has a price to earnings ratio (PE ratio) of -0.44.

BCDA Latest News

BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application

SUNNYVALE, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...

CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes™ for the Treatment of Acute Myocardial Infarction

MULHOUSE, France, and SUNNYVALE, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and BioCardia...

BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach

SUNNYVALE, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and...

BioCardia Announces Reverse Stock Split

SUNNYVALE, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...

BioCardia Reports First Quarter 2024 Business Highlights and Financial Results

SUNNYVALE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...

BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes

SUNNYVALE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.4313-13.56289308183.183.662.72078103.41858676CS
4-0.3113-10.17320261443.063.662.62879713.26135425CS
12-2.8043-50.50063028995.5536.152.622473794.2310665CS
26-3.6413-56.98435054776.398.852.622938315.5993105CS
52-17.0513-86.117676767719.823.252.6284632613.28673613CS
156-52.9013-95.060736747555.6559.42.6248956721.11104166CS
260-75.8513-96.502926208778.61292.6251699945.20404085CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MIRAMIRA Pharmaceuticals Inc
$ 5.01
(627.35%)
151.42M
CMAXCareMax Inc
$ 5.7101
(261.40%)
100.56M
NUKKNukkleus Inc
$ 0.5415
(69.22%)
24.87M
SNOASonoma Pharmaceuticals Inc
$ 0.423
(37.34%)
4.57M
LPSNLivePerson Inc
$ 1.2999
(31.30%)
8.57M
CGBSCrown LNG Holdings Ltd
$ 0.9902
(-29.77%)
3.29M
LGCBLinkage Global Inc
$ 3.7833
(-27.45%)
166.7k
SPECSpectaire Holdings Inc
$ 0.395
(-24.76%)
1.78M
GSUNGolden Sun Health Technology Group Ltd
$ 5.07
(-24.55%)
155.37k
SLNASelina Hospitality PLC
$ 0.0364
(-23.04%)
75.77M
NVDANVIDIA Corporation
$ 123.54
(4.76%)
239M
SQQQProShares UltraPro Short QQQ
$ 8.09
(-4.37%)
183.65M
MIRAMIRA Pharmaceuticals Inc
$ 5.01
(627.35%)
158.15M
SERVServe Robotics Inc
$ 8.73
(15.63%)
151.56M
NCPLNetcapital Inc
$ 0.1118
(7.50%)
124.37M

BCDA Discussion

View Posts
Monksdream Monksdream 2 days ago
BCDA under $3
👍️0
JB40 JB40 3 weeks ago
Understand and agree. They get little to no traction on the market. Although, most important imo is they do get traction with the largest health insurer in the country putting millions into BCDA's trials. Bizarre to me that few are paying attention to such a large indication as I'm sure you are aware with them being in such a late stage of their trials. Small burn and only need a small amount of capital to get to the Phase 3 readout. They already have 90% of the Phase 3 BCDA01 data, so I guess we will see what happens with the final data set.
👍️0
murocman murocman 3 weeks ago
Yes. Have a personal interest as I have heart disease.

Have traded it sporadically.

Disappointed that don’t ever seem to get much traction with this therapy even with good data.

Murocman
👍️0
JB40 JB40 3 weeks ago
Been tracking this company for years. Anyone else?
👍️0
Monksdream Monksdream 1 month ago
BCDA new 52 week low
👍️0
Muhbruh Muhbruh 1 month ago
$BCDA catalysts;
''Our planned Morph-DNA submission to the FDA for approval of a product family from 5 French to 8 French diameters is on track for submission in the second quarter of 2024''
''Q2: Enrollment in the CardiAMP Cell Therapy Heart Failure Trial''
''Q2: Completion of low dose cohort''
''Q2: Third revenue sharing partnership agreement''
👍️0
Monksdream Monksdream 1 month ago
BCDA new 52 week low
👍️0
Monksdream Monksdream 1 month ago
BCDA new 52 week low
👍️0
tw0122 tw0122 1 month ago
Watching news .. 08:17 AM EDT, 06/07/2024 (MT Newswires) -- BioCardia (BCDA) said Friday that the US Patent Office has granted a patent for the company's radial and transendocardial biotherapeutic delivery catheter through 2036.

The Helix biotherapeutic delivery system is being evaluated in ongoing clinical trials, according to BioCardia. It relates to medical procedures and systems for substance delivery to the heart through a radial artery and for the intracardiac delivery of cellular aggregates and other materials, the company said.

BioCardia's stock climbed more than 44% in recent Friday premarket activity.

Price: 6.3000, Change: +1.93, Percent Change: +44.16
👍️0
Termite7 Termite7 2 months ago
Keep watching.........
👍️0
TheGreenReaper TheGreenReaper 8 months ago
Let's get a rise back up
👍️0
Triple nickle Triple nickle 8 months ago
Easy money
👍️0
Triple nickle Triple nickle 8 months ago
Grabbed 1.20
👍️0
Triple nickle Triple nickle 8 months ago
Got 1.28’s now to push it
👍️0
Triple nickle Triple nickle 8 months ago
Tapping it up
👍️0
subslover subslover 8 months ago
Already past Pluto now heading for the next solar system
👍️0
Triple nickle Triple nickle 8 months ago
1.94 in the works
👍️0
knrorrel knrorrel 8 months ago
great
👍️0
TheFinalCD TheFinalCD 8 months ago
https://dilutiontracker.com/app/search/BCDA
👍️0
TheFinalCD TheFinalCD 8 months ago
$BCDA NEWS https://finviz.com/quote.ashx?t=BCDA&p=d

https://dilutiontracker.com/app/search/BCDA
👍️0
subslover subslover 8 months ago
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
SUNNYVALE, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the Food and Drug Administration (FDA) approval of its Phase III clinical trial of its CardiAMP autologous cell therapy for the treatment of patients with ischemic heart failure.

BioCardia announces that the Food and Drug Administration (FDA) has approved its proposed CardiAMP Heart Failure II study protocol. The currently ongoing CardiAMP Heart Failure trial has completed enrollment and it is anticipated that the final data analyses will be reported in Q4 2024. In an interim analysis of available data to date for study patients followed up through two years, those having N-terminal pro B-type natriuretic peptide (NT-proBNP) levels consistent as demarcating heart failure (>500 pg/ml) at screening-baseline showed meaningful clinical improvements over controls, including a 59% relative risk reduction in heart death and a 54% relative risk reduction of Major Adverse Cardiovascular or Cerebrovascular events (MACCE). Further, all clinical outcome measures evaluated at follow-up for this interim subset favored cell therapy over guideline directed medical therapy, including having improved quality-of-life as measured using the Minnesota Living with Heart Failure Questionnaire, reduced NT-proBNP levels, greater walk distance as measured using the 6-minute walk distance test, and improved cardiac measures such as left ventricular ejection fraction and left ventricular end systolic and end diastolic volumes. Statistical significance (p
👍️0
Awl416 Awl416 8 months ago
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
👍️0
Biggiee Biggiee 9 months ago
Let’s do this
👍️0
Monksdream Monksdream 10 months ago
BCDA new 52 week low
👍️0
Monksdream Monksdream 10 months ago
BCDA new 52 week low
👍️0
Monksdream Monksdream 10 months ago
BCDA new 52 week low
👍️0
Monksdream Monksdream 10 months ago
BCDA new 52 week low
👍️0
Monksdream Monksdream 11 months ago
BCDA new 52 week low
👍️0
stock1ace1 stock1ace1 11 months ago
Bad news out .62 watch for the dump today
👍️0
Monksdream Monksdream 11 months ago
BCDA new 52 week low
👍️0
Monksdream Monksdream 11 months ago
BCDA new 52 week low
👍️0
Monksdream Monksdream 11 months ago
BCDA new 52 week low
👍️0
Monksdream Monksdream 12 months ago
BCDA new 52 week low
👍️0
willlbone willlbone 12 months ago
Shady day in Sunnyvale.
👍️0
PStockPickz PStockPickz 2 years ago
Nice open
👍️0
PStockPickz PStockPickz 2 years ago
Grabbed some $2.86
👍️0
PStockPickz PStockPickz 2 years ago
Time for another leg up!
👍️0
PStockPickz PStockPickz 2 years ago
https://finance.yahoo.com/news/biocardia-announces-fda-approval-ind-111500114.html
👍️0
PStockPickz PStockPickz 2 years ago
Looking good
👍️0
Awl416 Awl416 2 years ago
News
👍️0
Pro_Stock_Trader Pro_Stock_Trader 2 years ago
Going to be retesting highs here during power hour or after hours
👍️0
wesley_ wesley_ 3 years ago
$3.70 nice :)
👍️0
mplscubfan mplscubfan 3 years ago
Looking good here
👍️0
wesley_ wesley_ 3 years ago
$4.85 next leg up :)
👍️0
ClayTrader ClayTrader 4 years ago
* * $BCDA Video Chart 12-15-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ipo_dude ipo_dude 4 years ago
They anticipate .. not definitive
👍️0
Glider549 Glider549 4 years ago
Phase 3 DSMB feedback due December 17th
👍️0
ClayTrader ClayTrader 4 years ago
* * $BCDA Video Chart 12-14-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
Pedro2004 Pedro2004 4 years ago
There we go. Finally broke $6.00 -- but the dump brought-it back to $5.75
👍️0
Pedro2004 Pedro2004 4 years ago
Someone keeps dumping blocks. But I'm keeping an eye on this the next few days.
👍️0

Your Recent History

Delayed Upgrade Clock